MMED · MiniMed Group, Inc.
$19.49
+0.57 (+3.01%)
At close · Aug 26
Market Cap
$5.39B
Shares
280.84M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$3.1B
FY2026
Net Income
-$333M
FY2026
Gross Margin
54.16%
FY2026
Operating Margin
-6.13%
FY2026
Diluted EPS
-$1.30
FY2026
Operating Cash Flow
-$197M
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 |
|---|---|
| $3.1B | |
| $1.42B | |
| $1.68B | |
| 54.16% | |
| $448M | |
| $1.18B | |
| $26M | |
| $156M | |
| -$190M | |
| -6.13% | |
| -$34M | |
| $1M | |
| -$189M | |
| $128M | |
| -$333M | |
| -10.74% | |
| $16M | |
| -$297M | |
| USD/shares | -$1.30 |
| USD/shares | -$1.30 |
| shares | 256.6M |
| shares | 256.6M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Non Us | $2,185,000,000 | $1,812,000,000 | $1,636,000,000 |
| United States | $917,000,000 | $903,000,000 | $833,000,000 |
By Product & Service (USD)
| Component | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Continuous Glucose Monitoring Systems (CGM) | $1,553,000,000 | $1,313,000,000 | $1,117,000,000 |
| Consumables | $956,000,000 | $854,000,000 | $777,000,000 |
| Pumps | $546,000,000 | $541,000,000 | $540,000,000 |
| Product And Service Other | $46,000,000 | $6,000,000 | $34,000,000 |
Key facts
CIK
2062583
CUSIP
60365F109
13F (30d)
91 filings
91 filers
Visit website
Investor relations